The phase 3 PIVOT-006 registration trial demonstrates an unprecedented improvement in recurrence-free survival (RFS) for intermediate- and high-grade Ta Non-Muscle Invasive Bladder Cancer (NMIBC).
The phase 3 PIVOT-006 registration trial demonstrates an unprecedented improvement in recurrence-free survival (RFS) for intermediate- and high-grade Ta Non-Muscle Invasive Bladder Cancer (NMIBC).
Want to see every report in real time?
Hundreds of sources worldwide, translated into your language, with alerts for what matters to you.
Sign up free Already have an account? Log in